Eisai Co., Ltd.Tokyo Japan
Company Description
Eisai develops, manufactures, and distributes prescription pharmaceuticals, primarily in North America and Japan. Prescription drug sales account for a majority of the company's revenues and are led by Aricept, which treats Alzheimer's disease. Other drugs include Myonal, a muscle relaxant, and Pariet (known as AcipHex in the US) an acid reflux and ulcer treatment. Development programs target neurology, oncology, vascular, and immunological ailments. In addition, in Japan Eisai distributes over-the-counter drugs and consumer health products. The company also makes chemical active pharmaceutical ingredients (APIs).
| 4-6-10 Koishikawa, Bunkyo-Ku | Phone: +81-3-3817-3700 | http://www.eisai.co.jp |
| Tokyo 112-8088 | Fax: +81-3-3811-3077 | 
Map This Company |
| Japan |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Eisai Co., Ltd. Rankings
| Nikkei 225 |
Executives
| 37 executives listed for Eisai Co., Ltd.'s Tokyo, Japan location. |
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Employees | 11,560 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Eisai Co., Ltd. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
